Stereotactic body radiotherapy (SBRT) for intrahepatic and Hilar cholangiocarcinoma

Journal of Cancer

Volumn 6, Issue 11, 2015, Pages 1099-1104

  Mahadevan, Anand ^a   Dagoglu, Nergiz ^a   Mancias, Joseph ^a   Raven, Kristin ^a   Khwaja, Khalid ^a   Tseng, Jennifer F ^a   Ng, Kimmie ^a   Enzinger, Peter ^a   Miksad, Rebecca ^a   Bullock, Andrea ^a   Evenson, Amy ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cholangiocarcinomas; Stereotactic body radiotherapy

Indexed keywords

CISPLATIN; GEMCITABINE;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CHOLANGITIS; CLINICAL ARTICLE; CYBERKNIFE; DUODENUM ULCER; FATIGUE; FEMALE; FOLLOW UP; HUMAN; LIVER ABSCESS; MALE; MEDICAL ONCOLOGIST; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; RADIATION SICKNESS; STEREOTACTIC BODY RADIATION THERAPY; SYSTEMIC THERAPY; TUMOR VOLUME; VERY ELDERLY;

EID: 84947779987     PISSN: None     EISSN: 18379664     Source Type: Journal    
DOI: 10.7150/jca.13032     Document Type: Article

References (50)

1. Olnes MJ, Erlich R. A Review and Update on Cholangiocarcinoma. Oncology. 2004;66(3):167-79.
2. de Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM. Biliary tract cancers. N Engl J Med. 1999 Oct 28;341(18):1368-78.
3. Tyson GL, Ilyas JA, Duan Z, Green LK, Younes M, El-Serag HB, et al. Secular Trends in the Incidence of Cholangiocarcinoma in the USA and the Impact of Misclassification. Dig Dis Sci. 2014 Sep 10;
4. Aljiffry M. Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009. World J Gastroenterol. 2009 Jan 1;15(34):4240.
5. Robles R, Sánchez-Bueno F, Ramírez P, Brusadin R, Parrilla P. Liver transplantation for hilar cholangiocarcinoma. World J Gastroenterol WJG. 2013 Dec 28;19(48):9209-15.
6. Nagorney DM, Donohue JH, Farnell MB, Schleck CD, Ilstrup DM. Outcomes after curative resections of cholangiocarcinoma. Arch Surg Chic Ill 1960. 1993 Aug;128(8):871-7; discussion 877-9.
7. Nagino M, Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, et al. Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections. Ann Surg. 2013 Jul;258(1):129-40.
8. Crane CH, Macdonald KO, Vauthey JN, Yehuda P, Brown T, Curley S, et al. Limitations of conventional doses of chemoradiation for unresectable biliary cancer. Int J Radiat Oncol Biol Phys. 2002;53(4):969-74.
9. Alden ME, Mohiuddin M. The impact of radiation dose in combined external beam and intraluminal Ir-192 brachytherapy for bile duct cancer. Int J Radiat Oncol Biol Phys. 1994 Mar 1;28(4):945-51.
10. Valle JW, Furuse J, Jitlal M, Beare S, Mizuno N, Wasan H, et al. Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials. Ann Oncol Off J Eur Soc Med Oncol ESMO. 2014 Feb;25(2):391-8.
11. Mahadevan A, Miksad R, Goldstein M, Sullivan R, Bullock A, Buchbinder E, et al. Induction gemcitabine and stereotactic body radiotherapy for locally advanced nonmetastatic pancreas cancer. Int J Radiat Oncol Biol Phys. 2011;
12. Chang DT, Schellenberg D, Shen J, Kim J, Goodman KA, Fisher GA, et al. Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas. Cancer. 2009 Feb 1;115(3):665-72.
13. Rusthoven KE, Kavanagh BD, Cardenes H, Stieber VW, Burri SH, Feigenberg SJ, et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol Off J Am Soc Clin Oncol. 2009 Apr 1;27(10):1572-8.
14. Mahadevan A, Jain S, Goldstein M, Miksad R, Pleskow D, Sawhney M, et al. Stereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2010;78(3):735-42.
15. DeOliveira ML, Cunningham SC, Cameron JL, Kamangar F, Winter JM, Lillemoe KD, et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg. 2007;245(5):755.
16. Farges O, Fuks D, Boleslawski E, Le Treut Y-P, Castaing D, Laurent A, et al. Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study group. Ann Surg. 2011;254(5):824-30.
17. Nagino M, Kamiya J, Nishio H, Ebata T, Arai T, Nimura Y. Two Hundred Forty Consecutive Portal Vein Embolizations Before Extended Hepatectomy for Biliary Cancer: Surgical Outcome and Long-term Follow-Up. Ann Surg. 2006 Mar;243(3):364-72.
18. Rosen CB, Heimbach JK, Gores GJ. Liver transplantation for cholangiocarcinoma: Transplantation for cholangiocarcinoma. Transpl Int. 2010 Mar 11;23(7):692-7.
19. Forsmo Havard M, Horn A, Viste A, Hoem D, Ovrebo K. Survival and an overview of decision-making in patients with cholangiocarcinoma. Hepatobiliary Pancreat Int. 2008;7(4):412-7.
20. Grove MK, Hermann RE, Vogt DP, Broughan TA. Role of radiation after operative palliation in cancer of the proximal bile ducts. Am J Surg. 1991 Apr;161(4):454-8.
21. Veeze-Kuijpers B, Meerwaldt JH, Lameris JS, van Blankenstein M, van Putten WL, Terpstra OT. The role of radiotherapy in the treatment of bile duct carcinoma. Int J Radiat Oncol Biol Phys. 1990 Jan;18(1):63-7.
22. Brunner TB, Eccles CL. Radiotherapy and Chemotherapy as Therapeutic Strategies in Extrahepatic Biliary Duct Carcinoma. Strahlenther Onkol. 2010 Dec;186(12):672-80.
23. Ghafoori AP, Nelson JW, Willett CG, Chino J, Tyler DS, Hurwitz HI, et al. Radiotherapy in the Treatment of Patients With Unresectable Extrahepatic Cholangiocarcinoma. Int J Radiat Oncol. 2011 Nov;81(3):654-9.
24. Vern-Gross TZ, Shivnani AT, Chen K, Lee CM, Tward JD, MacDonald OK, et al. Survival outcomes in resected extrahepatic cholangiocarcinoma: effect of adjuvant radiotherapy in a surveillance, epidemiology, and end results analysis. Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1):189-98.
25. Nakeeb A, Pitt H. Radiation therapy, chemotherapy and chemoradiation in hilar cholangiocarcinoma. HPB. 2005 Dec 1;7(4):278-82.
26. Deodato F, Clemente G, Mattiucci GC, Macchia G, Costamagna G, Giuliante F, et al. Chemoradiation and brachytherapy in biliary tract carcinoma: Long-term results. Int J Radiat Oncol. 2006 Feb;64(2):483-8.
27. Montemaggi P, Costamagna G, Dobelbower RR, Cellini N, Morganti AG, Mutignani M, et al. Intraluminal brachytherapy in the treatment of pancreas and bile duct carcinoma. Int J Radiat Oncol Biol Phys. 1995 May 15;32(2):437-43.
28. Takamura A, Saito H, Kamada T, Hiramatsu K, Takeuchi S, Hasegawa M, et al. Intraluminal low-dose-rate 192Ir brachytherapy combined with external beam radiotherapy and biliary stenting for unresectable extrahepatic bile duct carcinoma. Int J Radiat Oncol. 2003 Dec;57(5):1357-65.
29. Foo ML, Gunderson LL, Bender CE, Buskirk SJ. External radiation therapy and transcatheter iridium in the treatment of extrahepatic bile duct carcinoma. Int J Radiat Oncol Biol Phys. 1997 Nov 1;39(4):929-35.
30. Mattiucci GC, Autorino R, Agostino GR D', Deodato F, Macchia G, Perri V, et al. Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma. Crit Rev Oncol Hematol. 2014 Apr;90(1):58-67.
31. González González D, Gerard JP, Maners AW, la Lande-Guyaux B De, Van Dijk-Milatz A, Meerwaldt JH, et al. Results of radiation therapy in carcinoma of the proximal bile duct (Klatskin tumor). Semin Liver Dis. 1990 May;10(2):131-41.
32. Cameron JL, Pitt HA, Zinner MJ, Kaufman SL, Coleman J. Management of proximal cholangiocarcinomas by surgical resection and radiotherapy. Am J Surg. 1990 Jan;159(1):91-7; discussion 97-8.
33. Gerhards MF, van Gulik TM, González González D, Rauws EAJ, Gouma DJ. Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma. World J Surg. 2003 Feb;27(2):173-9.
34. Gwak HK, Kim WC, Kim HJ, Park JH. Extrahepatic bile duct cancers: surgery alone versus surgery plus postoperative radiation therapy. Int J Radiat Oncol Biol Phys. 2010 Sep 1;78(1):194-8.
35. Nelson JW, Ghafoori AP, Willett CG, Tyler DS, Pappas TN, Clary BM, et al. Concurrent Chemoradiotherapy in Resected Extrahepatic Cholangiocarcinoma. Int J Radiat Oncol. 2009 Jan;73(1):148-53.
36. Beltrán MB, Roth AD, Mentha G, Allal AS. Adjuvant radio-chemotherapy for extrahepatic biliary tract cancers. BMC Cancer. 2011;11(1):267.
37. Pitt HA, Nakeeb A, Abrams RA, Coleman J, Piantadosi S, Yeo CJ, et al. Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival. Ann Surg. 1995;221(6):788.
38. Koong AC, Le QT, Ho A, Fong B, Fisher G, Cho C, et al. Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1017-21.
39. Schellenberg D, Kim J, Christman-Skieller C, Chun CL, Columbo LA, Ford JM, et al. Single-Fraction Stereotactic Body Radiation Therapy and Sequential Gemcitabine for the Treatment of Locally Advanced Pancreatic Cancer. Int J Radiat Oncol Biol Phys. 2011;
40. Tse RV, Hawkins M, Lockwood G, Kim JJ, Cummings B, Knox J, et al. Phase I Study of Individualized Stereotactic Body Radiotherapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma. J Clin Oncol. 2008 Feb 1;26(4):657-64.
41. Didolkar MS, Coleman CW, Brenner MJ, Chu KU, Olexa N, Stanwyck E, et al. Image-guided stereotactic radiosurgery for locally advanced pancreatic adenocarcinoma results of first 85 patients. J Gastrointest Surg Off J Soc Surg Aliment Tract. 2010 Oct;14(10):1547-59.
42. Herfarth KK, Debus J, Lohr F, Bahner ML, Rhein B, Fritz P, et al. Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. J Clin Oncol Off J Am Soc Clin Oncol. 2001 Jan 1;19(1):164-70.
43. Goodman KA, Wiegner EA, Maturen KE, Zhang Z, Mo Q, Yang G, et al. Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies. Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):486-93.
44. Polistina FA, Guglielmi R, Baiocchi C, Francescon P, Scalchi P, Febbraro A, et al. Chemoradiation treatment with gemcitabine plus stereotactic body radiotherapy for unresectable, non-metastatic, locally advanced hilar cholangiocarcinoma. Results of a five year experience. Radiother Oncol. 2011 May;99(2):120-3.
45. Barney BM, Olivier KR, Miller RC, Haddock MG. Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma. Radiat Oncol. 2012;7(1):67.
46. Welling TH, Feng M, Wan S, Hwang SY, Volk ML, Lawrence TS, et al. Neoadjuvant stereotactic body radiation therapy, capecitabine, and liver transplantation for unresectable hilar cholangiocarcinoma: SBRT/Capecitabine and Liver Transplantation for CCA. Liver Transpl. 2014 Jan;20(1):81-8.
47. Kopek N, Holt MI, Hansen AT, Hoyer M. Stereotactic body radiotherapy for unresectable cholangiocarcinoma. Radiother Oncol. 2010;94(1):47-52.
48. Xu Q, Hanna G, Grimm J, Kubicek G, Pahlajani N, Asbell S, et al. Quantifying Rigid and Nonrigid Motion of Liver Tumors During Stereotactic Body Radiation Therapy. Int J Radiat Oncol. 2014 Sep;90(1):94-101.
49. Sterzing F, Brunner TB, Ernst I, Baus WW, Greve B, Herfarth K, et al. Stereotactic body radiotherapy for liver tumors: Principles and practical guidelines of the DEGRO Working Group on Stereotactic Radiotherapy. Strahlenther Onkol. 2014 Oct;190(10):872-81.
50. Schweikard A, Glosser G, Bodduluri M, Murphy MJ, Adler JR. Robotic motion compensation for respiratory movement during radiosurgery. Comput Aided Surg Off J Int Soc Comput Aided Surg. 2000;5(4):263-77.